Medical Director · Curex
Dr. Chet TharpeMD
Allergy and Immunology · 15+ years in practice
- years in practice
- 15+years in practice
- board certifications
- 2board certifications
- peer-reviewed studies
- 2peer-reviewed studies
Biography
Dr. Chet Tharpe serves as Medical Director at Curex, where he oversees clinical protocols for sublingual immunotherapy and reviews patient treatment plans. He has spent more than 15 years treating allergic rhinitis, asthma, and environmental sensitivities, and is a published voice in the field of at-home allergen immunotherapy. In 2026 he co-authored a peer-reviewed real-world study in Frontiers in Allergy analyzing outcomes of telemedicine-delivered sublingual immunotherapy across 2,897 patients. Dr. Tharpe is a member of the American Academy of Allergy, Asthma & Immunology (AAAAI) and the American College of Allergy, Asthma & Immunology (ACAAI).
Published research
2 peer-reviewed publications, indexed in PubMed.
Peer-reviewed research · authored
Real-world outcomes of personalized sublingual immunotherapy for environmental allergies delivered through a telemedicine platform: a retrospective longitudinal cohort study
Frontiers in Allergy · 2026